{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:51:53Z","timestamp":1761486713115},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1053\/sonc.2002.30146","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T23:46:10Z","timestamp":1030232770000},"page":"98-104","source":"Crossref","is-referenced-by-count":14,"special_numbering":"S2","title":["Advances in classification and therapy of indolent B-cell malignancies"],"prefix":"10.1053","volume":"29","author":[{"given":"Thomas J","family":"Kipps","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/sonc.2002.30146_BIB1","first-page":"927","article-title":"Lymphocyte ontogeny","author":"LeBien","year":"2001"},{"key":"10.1053\/sonc.2002.30146_BIB2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jlb.66.2.224","article-title":"Dendritic cells directly modulate B cell growth and differentiation","volume":"66","author":"Dubois","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1053\/sonc.2002.30146_BIB3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/08830189709068178","article-title":"Human B cell biology","volume":"15","author":"Kipps","year":"1997","journal-title":"Int Rev Immunol"},{"key":"10.1053\/sonc.2002.30146_BIB4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0952-7915(99)80031-4","article-title":"Hypermutation in antibody affinity maturation","volume":"11","author":"Wabl","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"10.1053\/sonc.2002.30146_BIB5","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood.V70.5.1316.1316","article-title":"Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development","volume":"70","author":"Loken","year":"1987","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30146_BIB6","first-page":"1137","article-title":"Classification of malignant lymphoid disorders","author":"Kipps","year":"2001"},{"issue":"suppl 1","key":"10.1053\/sonc.2002.30146_BIB7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/annonc\/11.suppl_1.S107","article-title":"Treatment of multiple myeloma by antibody mediated immunotherapy and induction of myeloma selective antigens","volume":"11","author":"Treon","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1053\/sonc.2002.30146_BIB8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/jcp.51.5.364","article-title":"Levels of expression of CD19 and CD20 in chronic B cell leukaemias","volume":"51","author":"Ginaldi","year":"1998","journal-title":"J Clin Pathol"},{"key":"10.1053\/sonc.2002.30146_BIB9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/cyto.1071","article-title":"Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: Evidence from phenotyping after Rituxan therapy and transfectant cell analyses","volume":"46","author":"Serke","year":"2001","journal-title":"Cytometry"},{"key":"10.1053\/sonc.2002.30146_BIB10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/10428199909050957","article-title":"S-phase induction by interleukin-6 followed by chemotherapy in patients with chronic lymphocytic leukemia and non-Hodgkin's lymphoma","volume":"34","author":"Brown","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/sonc.2002.30146_BIB11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0145-2126(99)00206-4","article-title":"Effects of cytokines on CD20 antigen expression on tumor cells from patients with chronic lymphocytic leukemia","volume":"24","author":"Venugopal","year":"2000","journal-title":"Leuk Res"},{"key":"10.1053\/sonc.2002.30146_BIB12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ijc.1018","article-title":"Ionizing radiation induces CD20 surface expression on human B cells","volume":"96","author":"Kunala","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1053\/sonc.2002.30146_BIB13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0145-2126(00)00098-9","article-title":"Influence of various cytokines on the expression of CD20 on the surface of CLL-cells in vitro","volume":"25","author":"Chow","year":"2001","journal-title":"Leuk Res"},{"key":"10.1053\/sonc.2002.30146_BIB14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1309\/F5WE-K2T8-BT9D-Q56D","article-title":"Large cell lymphoma transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma. A flow cytometric analysis of seven cases","volume":"115","author":"Kroft","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/sonc.2002.30146_BIB15","first-page":"354","article-title":"Multiparameter flow cytometric analysis of human fetal bone marrow B cells","volume":"4","author":"LeBien","year":"1990","journal-title":"Leukemia"},{"key":"10.1053\/sonc.2002.30146_BIB16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01954514","article-title":"Distribution of lymphocyte surface antigens in healthy neonates","volume":"153","author":"Kontny","year":"1994","journal-title":"Eur J Pediatr"},{"key":"10.1053\/sonc.2002.30146_BIB17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1101\/sqb.1999.64.71","article-title":"The lymphochip: A specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes","volume":"64","author":"Alizadeh","year":"1999","journal-title":"Cold Spring Harbor Symposia on Quantitative Biology"},{"key":"10.1053\/sonc.2002.30146_BIB18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1053\/sonc.2002.30146_BIB19","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors","volume":"102","author":"Fais","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1053\/sonc.2002.30146_BIB20","doi-asserted-by":"crossref","first-page":"820","DOI":"10.4049\/jimmunol.160.2.820","article-title":"Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+ IgM+ chronic lymphocytic leukemia B cells: A multiple time point analysis","volume":"160","author":"Schettino","year":"1998","journal-title":"J Immunol"},{"key":"10.1053\/sonc.2002.30146_BIB21","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1182\/blood.V89.11.4153","article-title":"Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities","volume":"89","author":"Oscier","year":"1997","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30146_BIB22","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30146_BIB23","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30146_BIB24","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1073\/pnas.86.15.5913","article-title":"Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia","volume":"86","author":"Kipps","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/sonc.2002.30146_BIB25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4049\/jimmunol.158.1.235","article-title":"Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features","volume":"158","author":"Johnson","year":"1997","journal-title":"J Immunol"},{"key":"10.1053\/sonc.2002.30146_BIB26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4049\/jimmunol.166.1.95","article-title":"Normal B cells express 51p1-encoded Ig heavy chains that are distinct from those expressed by chronic lymphocytic leukemia B cells","volume":"166","author":"Widhopf","year":"2001","journal-title":"J Immunol"},{"key":"10.1053\/sonc.2002.30146_BIB27","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1084\/jem.175.4.983","article-title":"Evidence for somatic selection of natural autoantibodies","volume":"175","author":"Martin","year":"1992","journal-title":"J Exp Med"},{"key":"10.1053\/sonc.2002.30146_BIB28","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.4049\/jimmunol.152.12.5988","article-title":"Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain","volume":"152","author":"Martin","year":"1994","journal-title":"J Immunol"},{"key":"10.1053\/sonc.2002.30146_BIB29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1749-6632.1995.tb55834.x","article-title":"Developmental regulation of the human antibody repertoire","volume":"764","author":"Schroeder","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/sonc.2002.30146_BIB30","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","article-title":"IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma","volume":"90","author":"Maloney","year":"1997","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30146_BIB31","first-page":"1927","article-title":"Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase II study","volume":"92","author":"Coiffier","year":"1998","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30146_BIB32","first-page":"79","article-title":"Rituximab in indolent lymphoma: The single-agent pivotal trial","volume":"26","author":"McLaughlin","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1053\/sonc.2002.30146_BIB33","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.30146_BIB34","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1200\/JCO.2000.18.17.3135","article-title":"Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: Safety and efficacy of re-treatment","volume":"18","author":"Davis","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.30146_BIB35","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1200\/JCO.2001.19.8.2153","article-title":"Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity","volume":"19","author":"Byrd","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.30146_BIB36","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1200\/JCO.2001.19.8.2165","article-title":"Rituximab dose-escalation trial in chronic lymphocytic leukemia","volume":"19","author":"O'Brien","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.30146_BIB37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s002770050419","article-title":"Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab)","volume":"77","author":"Jensen","year":"1998","journal-title":"Ann Hematol"},{"key":"10.1053\/sonc.2002.30146_BIB38","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.1999.17.3.791","article-title":"Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: Association with increased infusion-related side effects and rapid blood tumor clearance","volume":"17","author":"Byrd","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2002.30146_BIB39","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1182\/blood.V94.7.2217.419k02_2217_2224","article-title":"Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8)","volume":"94","author":"Winkler","year":"1999","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30146_BIB40","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.4049\/jimmunol.151.5.2497","article-title":"The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells","volume":"151","author":"Roy","year":"1993","journal-title":"J Immunol"},{"key":"10.1053\/sonc.2002.30146_BIB41","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/eji.1830230430","article-title":"Expression of a 32-kDa ligand for the CD40 antigen on activated human T lymphocytes","volume":"23","author":"Hermann","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1053\/sonc.2002.30146_BIB42","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.4049\/jimmunol.151.4.1777","article-title":"Regulation of expression of the ligand for CD40 on T helper lymphocytes","volume":"151","author":"Castle","year":"1993","journal-title":"J Immunol"},{"key":"10.1053\/sonc.2002.30146_BIB43","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nm0997-984","article-title":"Acquired CD40-ligand deficiency in chronic lymphocytic leukemia","volume":"3","author":"Cantwell","year":"1997","journal-title":"Nat Med"},{"key":"10.1053\/sonc.2002.30146_BIB44","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1084\/jem.177.4.925","article-title":"Activated T cells induce expression of B7\/BB1 on normal or leukemic B cells through a CD40-dependent signal","volume":"177","author":"Ranheim","year":"1993","journal-title":"J Exp Med"},{"key":"10.1053\/sonc.2002.30146_BIB45","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1006\/cimm.1995.1031","article-title":"Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: Complex regulation by IL-4, IL-10, and CD40L","volume":"161","author":"Ranheim","year":"1995","journal-title":"Cell Immunol"},{"key":"10.1053\/sonc.2002.30146_BIB46","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jlb.63.4.418","article-title":"The role of CD40\/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells","volume":"63","author":"Mackey","year":"1998","journal-title":"J Leukoc Biol"},{"key":"10.1053\/sonc.2002.30146_BIB47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","article-title":"CD40 and CD154 in cell-mediated immunity","volume":"16","author":"Grewal","year":"1998","journal-title":"Ann Rev Immunol"},{"key":"10.1053\/sonc.2002.30146_BIB48","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI1472","article-title":"Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells","volume":"101","author":"Kato","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1053\/sonc.2002.30146_BIB49","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.4049\/jimmunol.161.4.1901","article-title":"Antitumor effect of CD40 ligand: Elicitation of local and systemic antitumor responses by IL-12 and B7","volume":"161","author":"Nakajima","year":"1998","journal-title":"J Immunol"},{"key":"10.1053\/sonc.2002.30146_BIB50","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1089\/10430349950018049","article-title":"Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells","volume":"10","author":"Kikuchi","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1053\/sonc.2002.30146_BIB51","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1182\/blood.V90.5.1927","article-title":"CD40 ligand induces an antileukemia immune response in vivo","volume":"90","author":"Dilloo","year":"1997","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30146_BIB52","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1182\/blood.V96.9.2917","article-title":"CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia","volume":"96","author":"Wierda","year":"2000","journal-title":"Blood"},{"key":"10.1053\/sonc.2002.30146_BIB53","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.1073\/pnas.92.18.8200","article-title":"Follicular lymphomas can be induced to present alloantigen efficiently: A conceptual model to improve their tumor immunogenicity","volume":"92","author":"Schultze","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/sonc.2002.30146_BIB54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nm0196-52","article-title":"Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells","volume":"2","author":"Hsu","year":"1996","journal-title":"Nat Med"},{"key":"10.1053\/sonc.2002.30146_BIB55","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/sj.leu.2402208","article-title":"T cell activation following infection of primary follicle center lymphoma B cells with adenovirus encoding CD154","volume":"15","author":"Cantwell","year":"2001","journal-title":"Leukemia"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775402500841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775402500841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:34:54Z","timestamp":1682123694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775402500841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0093775402500841"],"URL":"https:\/\/doi.org\/10.1053\/sonc.2002.30146","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}